Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii

Trial Profile

Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Schizoaffective disorder; Schizophrenia; Toxoplasmosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2018 Status changed from active, no longer recruiting to completed.
    • 24 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 24 Oct 2016 Planned End Date changed from 1 Mar 2015 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top